Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep274 | Calcium & Vitamin D metabolism | ECE2017

Calcifediol is more effective than cholecalciferol in the treatment of severe vitamin D deficiency in a patient submitted to malabsorbitive bariatric surgery: a case report

Brancatella Alessandro , Cappellani Daniele , Vignali Edda , Canale Domenico , Marcocci Claudio

Context: Vitamin D deficiency following malabsorptive bariatric surgery can lead to osteomalacia. We report a patient with severe vitamin D deficiency following malabsorptive bariatric surgery successfully treated with calcifediol but not cholecalciferol.Case description: A 40-year-old woman, submitted to biliopancreatic diversion 20 years before and chronically treated with 50 000 IU cholecalciferol weekly, was admitted to our Endocrine Unit because of ...

ea0049ep238 | Bone & Osteoporosis | ECE2017

Teriparatide discontinuation in a patient with post surgical hypoparathyroidism: a clinical challenge

Brancatella Alessandro , Apicella Matteo , Fiore Emilio , Ceccarini Giovanni , Vignali Edda , Marcocci Claudio , Vitti Paolo , Molinaro Eleonora

Context: Teriparatide may represent a possible treatment for hypoparathyroidism when oral supplementation with calcium and calcitriol fail to maintain adequate serum calcium level (SCL). The switch from teriparitide to oral calcium and calcitriol could be challenging and there is no consensus for clinical management.Case presentation: A 50-year-old man was admitted at our Department for teriparatide discontinuation. Three years before admission, the pati...

ea0049ep288 | Calcium & Vitamin D metabolism | ECE2017

Renal complications in patients with chronic postoperative hypoparathyroidism treated with oral calcium and active vitamin D metabolites

Cetani Filomena , Meola Antonella , Vignali Edda , Guglielmi Giovanni , Donato Irene , Matrone Antonio , Elisei Rossella , Marcocci Claudio

Patients with chronic hypoparathyroidism (HypoPT) treated with oral calcium and active vitamin D metabolites are at risk of renal complications, because of the lack of action of PTH at the renal tubule. In the present study we evaluated 90 patients (68 females and 22 males; age: 51.8±14.1 yrs) with chronic postoperative Hypo (PO-HypoPT) diagnosed since at least 3 years. All patients were treated with calcitriol and 35 (39%) with oral calcium two patients were also treated...

ea0022p103 | Bone/Calcium | ECE2010

Tumoral calcinosis likely due to end-organ resistance to FGF23

Cianferotti Luisella , Vignali Edda , Cetani Filomena , Galli Giulia , Giacomelli Tamara , Pinchera Aldo , Marcocci Claudio

Tumoral calcinosis is a rare autosomal recessive disease characterized by hyperphosphatemia due to increased renal phosphate reabsorption leading to soft tissue calcifications. The levels of fibroblast growth factor 23 (FGF23), a hormone required for normal renal phosphate reabsorption, are typically low in the classic form of the disease due to homozygous missense mutations in FGF23 or in the UDP-Nacetyl-alpha-D galactosamine:polypeptide N-acetylgalactos...

ea0014p399 | (1) | ECE2007

Prevalence of primary hyperparatiroidism in treated and untreated breast cancer

Giani Claudio , Fiore Emilio , Giustarini Elisa , Muller Ilaria , Vignali Edda , Fierabracci Paola , Pinchera Aldo

Hypercalcemia is a frequent metabolic disorder in metastatic breast cancer (BC). Aim of this study was to evaluate the incidence of hypercalcemia due to PHPT in BC patients. The study group included 271 consecutive BC, mean age±S.D. 57.7±11.96 yrs. 100/271(36.9%) evaluated at different times after mastectomy (A) and 171(63.1%) before surgery (B), with no distant metastases. Age matched control group included 108 healthy women (Co) and 70 women with thy...

ea0011p30 | Bone | ECE2006

Asymptomatic primary hyperparathyroidism: preliminary results of a prospetive randomized study on the effect of parathyroidectomy

Ambrogini E , Cianferotti L , Vignali E , Cetani F , Viccica G , Picone A , Miccoli P , Pinchera A , Marcocci C

Aim of this 2-year, prospective, randomized study is to compare the effect of parathyroidectomy (PTX) vs no treatment in patients with asymptomatic primary hyperparathyroidism (PHPT), who didn’t meet the 1991 NIH criteria for surgery. The study was approved by our local Ethical Committee. The primary endpoint was the change in lumbar spine bone mineral density (BMD); secondary endpoints were BMD changes at femur and distal radius, markers of bone turnover, quality ...

ea0011p462 | Endocrine tumours and neoplasia | ECE2006

Selective Cyclo-oxygenase 2 inhibitors revert chemoresistance In Medullary thyroid carcinoma by a mechanism mediated by P-gp and PGH2

Zatelli MC , Luchin A , pICCIN D , Tagliati F , Bottoni A , Vignali C , Bondanelli M , degli Uberti EC

Medullary thyroid carcinoma (MTC) is a malignant tumour deriving from parafollicular C cells, with a highly chemoresistant phenotype. Failure of medical therapy has been ascribed, at least in part, to multi drug resistance (MDR1) gene over-expression. MDR1 encodes for a transmembrane glycoprotein, P-gp, which hampers intracellular accumulation of cytotoxic drugs. It has been demonstrated that P-gp expression and function depend on cyclo-oxygenase 2 (COX-2) expression, which is...

ea0081p330 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Time of gestational diabetes diagnosis and neonatal outcomes

Morpurgo Paola S. , Peverelli Laura F. , Bolla Andrea M. , Gandolfi Alessandra , Vignali Michele , Spadaccini Giovanna , Fiorina Paolo

Background: The incidence of gestational diabetes mellitus (GDM) is increasing worldwide, with considerable impact on the health of both mother and newborn. There is no doubt that screening for GDM between 24 and 28 gestational weeks (GWks) is important to reduce the risk of adverse outcomes; however, there is no clear consensus about the diagnosis and treatment of GDM in early pregnancy.Aims: To evaluate the effect of time of GDM diagnosis (early onset ...

ea0037ep282 | Calcium and Vitamin D metabolism | ECE2015

A prospective study on juvenile primary hyperprathyroidism population

Saponaro Federica , Cacciatore Federica , Vignali Edda , Picone Antonella , Banti Chiara , Meola Antonella , Borsari Simona , Pardi Elena , Marcocci Claudio , Cetani Filomena

Primary hyperparathyroidism (PHPT) is a common disorder in adults but is uncommon in young people and features of juvenile PHPT (J-PHPT) are debated in literature. The aim of the study was to evaluate the characteristics of PHPT in juvenile sporadic (S) and familial (F) patients. It’s a monocentric prospective study at a referral centre in 154 patients with ≤40 years. Patients were evaluated at diagnosis and at the last follow-up visit (median follow-up 2 years), co...

ea0032p132 | Calcium and Vitamin D metabolism | ECE2013

Normocalcemic primary hyperparathyroidism: an Italian epidemiologic study

Vignali Edda , Meola Antonella , Centoni Roberta , Maria Gibilaro Rosa , Daniello Giuseppe , Cetani Filomena , Chiavistelli Silvia , Saponaro Federica , Marcocci Claudio

Primary hyperparathyroidism (PHPT) is defined by hypercalcemia and high PTH levels. In recent years a variant of PHPT has been described, namely normocalcemic PHPT (NPHPT), which is characterized by normal serum calcium and high PTH levels, in the absence of other causes of secondary hyperparathyroidism. The epidemiology of NPHPT is poorly understood. We performed a survey in the early fall in a small Southern Italian village, in which all adult residents (n=1811) wer...